Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
ATRI's Cash-to-Debt is ranked higher than
96% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. ATRI: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
ATRI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 32.22 Max: No Debt
Current: No Debt
Equity-to-Asset 0.89
ATRI's Equity-to-Asset is ranked higher than
94% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. ATRI: 0.89 )
Ranked among companies with meaningful Equity-to-Asset only.
ATRI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.76 Max: 0.89
Current: 0.89
0.25
0.89
Interest Coverage No Debt
ATRI's Interest Coverage is ranked higher than
95% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 44.21 vs. ATRI: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ATRI' s Interest Coverage Range Over the Past 10 Years
Min: 80.46  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 6
Altman Z-Score: 40.15
Beneish M-Score: -2.71
WACC vs ROIC
4.91%
26.73%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 27.50
ATRI's Operating Margin % is ranked higher than
94% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.72 vs. ATRI: 27.50 )
Ranked among companies with meaningful Operating Margin % only.
ATRI' s Operating Margin % Range Over the Past 10 Years
Min: 22.81  Med: 28.39 Max: 32.43
Current: 27.5
22.81
32.43
Net Margin % 22.74
ATRI's Net Margin % is ranked higher than
91% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. ATRI: 22.74 )
Ranked among companies with meaningful Net Margin % only.
ATRI' s Net Margin % Range Over the Past 10 Years
Min: 15.82  Med: 19.53 Max: 22.74
Current: 22.74
15.82
22.74
ROE % 20.33
ATRI's ROE % is ranked higher than
84% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.68 vs. ATRI: 20.33 )
Ranked among companies with meaningful ROE % only.
ATRI' s ROE % Range Over the Past 10 Years
Min: 15.48  Med: 17.96 Max: 20.41
Current: 20.33
15.48
20.41
ROA % 18.09
ATRI's ROA % is ranked higher than
93% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.36 vs. ATRI: 18.09 )
Ranked among companies with meaningful ROA % only.
ATRI' s ROA % Range Over the Past 10 Years
Min: 13.58  Med: 15.79 Max: 18.09
Current: 18.09
13.58
18.09
ROC (Joel Greenblatt) % 36.73
ATRI's ROC (Joel Greenblatt) % is ranked higher than
80% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.63 vs. ATRI: 36.73 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ATRI' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 26.8  Med: 39.39 Max: 48.1
Current: 36.73
26.8
48.1
3-Year Revenue Growth Rate 5.70
ATRI's 3-Year Revenue Growth Rate is ranked higher than
55% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.90 vs. ATRI: 5.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ATRI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -54.8  Med: 6.7 Max: 56.1
Current: 5.7
-54.8
56.1
3-Year EBITDA Growth Rate 3.90
ATRI's 3-Year EBITDA Growth Rate is ranked lower than
58% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. ATRI: 3.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ATRI' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -40.1  Med: 13.35 Max: 131.8
Current: 3.9
-40.1
131.8
3-Year EPS without NRI Growth Rate 4.10
ATRI's 3-Year EPS without NRI Growth Rate is ranked lower than
51% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. ATRI: 4.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ATRI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -51.8  Med: 17.65 Max: 59.9
Current: 4.1
-51.8
59.9
GuruFocus has detected 7 Warning Signs with Atrion Corp $ATRI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ATRI's 30-Y Financials

Financials (Next Earnings Date: 2017-11-03)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

ATRI Guru Trades in Q3 2016

Jim Simons 31,400 sh (+10.18%)
Chuck Royce 43,278 sh (-0.83%)
» More
Q4 2016

ATRI Guru Trades in Q4 2016

Jim Simons 33,200 sh (+5.73%)
Chuck Royce 42,878 sh (-0.92%)
» More
Q1 2017

ATRI Guru Trades in Q1 2017

Jim Simons 40,201 sh (+21.09%)
Chuck Royce 41,448 sh (-3.34%)
» More
Q2 2017

ATRI Guru Trades in Q2 2017

Columbia Wanger 21,700 sh (New)
Jim Simons 58,834 sh (+46.35%)
Chuck Royce 41,103 sh (-0.83%)
» More
» Details

Insider Trades

Latest Guru Trades with ATRI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NAS:IRTC, NYSE:GKOS, TSE:3593, SZSE:300171, ROCO:1565, NAS:OSUR, SZSE:300358, SZSE:300061, XKLS:7153, SZSE:300595, NAS:LMNX, XMCE:FAE, LSE:AMS, XKRX:048260, SHSE:603222, TSE:7730, SHSE:600288, NAS:ATRC, NAS:LMAT, SHSE:603987 » details
Headquarter Location:USA
Atrion Corp supplies medical devices and related components. The company makes various products such as fluid delivery devices and sells it worldwide. It aims to serve the patients with heart disease and eye problems.

Atrion Corp supplies medical devices and related components to the healthcare industry. The company primarily aims at issues relating to the heart and eye and offers products such as fluid delivery devices that are sold to users, distributors and other manufacturers worldwide. The firm generates most of its revenues from within the United States through the sale of fluid delivery products and cardiovascular products business.

Top Ranked Articles about Atrion Corp

Atrion Corporation Increases Quarterly Cash Dividend by 14%
Atrion Reports Second Quarter Results
Atrion Reports First Quarter Results
Atrion Corporation Announces Election of New Director

ALLEN, Texas, March 13, 2017 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced the election of Preston G. Athey as a director effective immediately. Mr. Athey recently retired after an extraordinary 38 year career with T. Rowe Price Associates. In 1991, he began managing the firm's Small-Cap Value Fund. Under his tutelage, fund assets grew from $45 million to $10 billion. Mr. Athey holds a BA degree from Yale University and an MBA degree from Stanford University. Mr. Athey brings a wealth of financial and operational experience, and will be another strong voice for our stockholders.
Atrion Corporation develops and manufactures products primarily for medical applications.  The Company’s website is www.atrioncorp.com.
Contact:
Jeffery Strickland
Vice President and Chief Financial Officer
(972) 390-9800


Read more...

Ratios

vs
industry
vs
history
PE Ratio 38.03
ATRI's PE Ratio is ranked lower than
63% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.08 vs. ATRI: 38.03 )
Ranked among companies with meaningful PE Ratio only.
ATRI' s PE Ratio Range Over the Past 10 Years
Min: 8.12  Med: 17.5 Max: 38.03
Current: 38.03
8.12
38.03
PE Ratio without NRI 38.03
ATRI's PE Ratio without NRI is ranked lower than
62% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. ATRI: 38.03 )
Ranked among companies with meaningful PE Ratio without NRI only.
ATRI' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.12  Med: 17.5 Max: 38.03
Current: 38.03
8.12
38.03
Price-to-Owner-Earnings 38.30
ATRI's Price-to-Owner-Earnings is ranked lower than
58% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.51 vs. ATRI: 38.30 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ATRI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.21  Med: 20.45 Max: 38.3
Current: 38.3
10.21
38.3
PB Ratio 7.26
ATRI's PB Ratio is ranked lower than
78% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. ATRI: 7.26 )
Ranked among companies with meaningful PB Ratio only.
ATRI' s PB Ratio Range Over the Past 10 Years
Min: 1.23  Med: 3.01 Max: 7.26
Current: 7.26
1.23
7.26
PS Ratio 8.66
ATRI's PS Ratio is ranked lower than
82% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.36 vs. ATRI: 8.66 )
Ranked among companies with meaningful PS Ratio only.
ATRI' s PS Ratio Range Over the Past 10 Years
Min: 1.36  Med: 3.49 Max: 8.66
Current: 8.66
1.36
8.66
Price-to-Free-Cash-Flow 39.70
ATRI's Price-to-Free-Cash-Flow is ranked lower than
68% of the 72 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.99 vs. ATRI: 39.70 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ATRI' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.41  Med: 21.17 Max: 427.38
Current: 39.7
7.41
427.38
Price-to-Operating-Cash-Flow 29.64
ATRI's Price-to-Operating-Cash-Flow is ranked lower than
67% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.95 vs. ATRI: 29.64 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ATRI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.98  Med: 13.8 Max: 29.64
Current: 29.64
5.98
29.64
EV-to-EBIT 30.19
ATRI's EV-to-EBIT is ranked lower than
62% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.17 vs. ATRI: 30.19 )
Ranked among companies with meaningful EV-to-EBIT only.
ATRI' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.6  Med: 11.6 Max: 30.19
Current: 30.19
4.6
30.19
EV-to-EBITDA 24.78
ATRI's EV-to-EBITDA is ranked lower than
69% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.83 vs. ATRI: 24.78 )
Ranked among companies with meaningful EV-to-EBITDA only.
ATRI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.6  Med: 9.4 Max: 24.78
Current: 24.78
3.6
24.78
EV-to-Revenue 8.31
ATRI's EV-to-Revenue is ranked lower than
80% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. ATRI: 8.31 )
Ranked among companies with meaningful EV-to-Revenue only.
ATRI' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.1  Med: 3.2 Max: 8.2
Current: 8.31
1.1
8.2
PEG Ratio 7.02
ATRI's PEG Ratio is ranked lower than
79% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. ATRI: 7.02 )
Ranked among companies with meaningful PEG Ratio only.
ATRI' s PEG Ratio Range Over the Past 10 Years
Min: 0.24  Med: 2.19 Max: 7.42
Current: 7.02
0.24
7.42
Shiller PE Ratio 51.43
ATRI's Shiller PE Ratio is ranked higher than
51% of the 51 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.91 vs. ATRI: 51.43 )
Ranked among companies with meaningful Shiller PE Ratio only.
ATRI' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.85  Med: 30.01 Max: 51.43
Current: 51.43
14.85
51.43
Current Ratio 10.97
ATRI's Current Ratio is ranked higher than
96% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. ATRI: 10.97 )
Ranked among companies with meaningful Current Ratio only.
ATRI' s Current Ratio Range Over the Past 10 Years
Min: 0.89  Med: 3.84 Max: 10.97
Current: 10.97
0.89
10.97
Quick Ratio 7.78
ATRI's Quick Ratio is ranked higher than
91% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. ATRI: 7.78 )
Ranked among companies with meaningful Quick Ratio only.
ATRI' s Quick Ratio Range Over the Past 10 Years
Min: 0.87  Med: 1.91 Max: 7.78
Current: 7.78
0.87
7.78
Days Inventory 143.44
ATRI's Days Inventory is ranked lower than
57% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.23 vs. ATRI: 143.44 )
Ranked among companies with meaningful Days Inventory only.
ATRI' s Days Inventory Range Over the Past 10 Years
Min: 114.19  Med: 132.65 Max: 143.44
Current: 143.44
114.19
143.44
Days Sales Outstanding 49.29
ATRI's Days Sales Outstanding is ranked higher than
71% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.37 vs. ATRI: 49.29 )
Ranked among companies with meaningful Days Sales Outstanding only.
ATRI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.8  Med: 40.01 Max: 49.29
Current: 49.29
34.8
49.29

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.63
ATRI's Dividend Yield % is ranked lower than
74% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.32 vs. ATRI: 0.63 )
Ranked among companies with meaningful Dividend Yield % only.
ATRI' s Dividend Yield % Range Over the Past 10 Years
Min: 0.63  Med: 0.87 Max: 1.74
Current: 0.63
0.63
1.74
Dividend Payout Ratio 0.24
ATRI's Dividend Payout Ratio is ranked higher than
70% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. ATRI: 0.24 )
Ranked among companies with meaningful Dividend Payout Ratio only.
ATRI' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.13  Med: 0.17 Max: 0.26
Current: 0.24
0.13
0.26
3-Year Dividend Growth Rate 17.60
ATRI's 3-Year Dividend Growth Rate is ranked higher than
71% of the 62 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.50 vs. ATRI: 17.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
ATRI' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.2 Max: 45.5
Current: 17.6
0
45.5
Forward Dividend Yield % 0.71
ATRI's Forward Dividend Yield % is ranked lower than
75% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.32 vs. ATRI: 0.71 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.35
ATRI's 5-Year Yield-on-Cost % is ranked lower than
52% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. ATRI: 1.35 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
ATRI' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.35  Med: 1.86 Max: 3.72
Current: 1.35
1.35
3.72
3-Year Average Share Buyback Ratio 2.90
ATRI's 3-Year Average Share Buyback Ratio is ranked higher than
96% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -4.10 vs. ATRI: 2.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ATRI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.6  Med: -0.2 Max: 17
Current: 2.9
-3.6
17

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 46.34
ATRI's Price-to-Net-Cash is ranked lower than
77% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.35 vs. ATRI: 46.34 )
Ranked among companies with meaningful Price-to-Net-Cash only.
ATRI' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 2.11  Med: 37.68 Max: 340.01
Current: 46.34
2.11
340.01
Price-to-Net-Current-Asset-Value 15.12
ATRI's Price-to-Net-Current-Asset-Value is ranked lower than
73% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.73 vs. ATRI: 15.12 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ATRI' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.58  Med: 9.73 Max: 372
Current: 15.12
1.58
372
Price-to-Tangible-Book 7.84
ATRI's Price-to-Tangible-Book is ranked lower than
70% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.82 vs. ATRI: 7.84 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ATRI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.54  Med: 2.38 Max: 7.84
Current: 7.84
0.54
7.84
Price-to-Intrinsic-Value-Projected-FCF 3.09
ATRI's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
61% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.18 vs. ATRI: 3.09 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ATRI' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.25  Med: 1.49 Max: 13.74
Current: 3.09
0.25
13.74
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.50
ATRI's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
62% of the 21 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. ATRI: 2.50 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
ATRI' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.39  Med: 1.19 Max: 2.37
Current: 2.5
0.39
2.37
Price-to-Median-PS-Value 2.48
ATRI's Price-to-Median-PS-Value is ranked lower than
93% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. ATRI: 2.48 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ATRI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.05  Med: 0.36 Max: 2.48
Current: 2.48
0.05
2.48
Price-to-Peter-Lynch-Fair-Value 6.65
ATRI's Price-to-Peter-Lynch-Fair-Value is ranked lower than
91% of the 44 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.18 vs. ATRI: 6.65 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ATRI' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.32  Med: 0.95 Max: 7.34
Current: 6.65
0.32
7.34
Price-to-Graham-Number 3.64
ATRI's Price-to-Graham-Number is ranked lower than
67% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. ATRI: 3.64 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ATRI' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.54  Med: 1.25 Max: 3.64
Current: 3.64
0.54
3.64
Earnings Yield (Greenblatt) % 3.31
ATRI's Earnings Yield (Greenblatt) % is ranked higher than
62% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. ATRI: 3.31 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ATRI' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.3  Med: 8.6 Max: 21.8
Current: 3.31
3.3
21.8
Forward Rate of Return (Yacktman) % 7.67
ATRI's Forward Rate of Return (Yacktman) % is ranked lower than
57% of the 97 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.48 vs. ATRI: 7.67 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ATRI' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -14.4  Med: 11.5 Max: 61.4
Current: 7.67
-14.4
61.4

More Statistics

Revenue (TTM) (Mil) $145.80
EPS (TTM) $ 17.85
Beta0.43
Short Percentage of Float1.86%
52-Week Range $418.00 - 694.00
Shares Outstanding (Mil)1.85

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}